结核病与糖尿病共病的治疗管理专家共识

2021-01-10 国家感染性疾病临床医学研究中心 中国防痨杂志, 2021,43(1):12-22.

结核病与糖尿病均是临床上的常见病和多发病,两者可合并存在,相互影响。活动性结核病作为感染因素可加重糖尿病病情,而糖尿病患者又是发生结核病的高危人群,结核病与糖尿病双重负担将成为重大的全球公共卫生问题。

中文标题:

结核病与糖尿病共病的治疗管理专家共识

发布日期:

2021-01-10

简要介绍:

结核病与糖尿病均是临床上的常见病和多发病,两者可合并存在,相互影响。活动性结核病作为感染因素可加重糖尿病病情,而糖尿病患者又是发生结核病的高危人群,结核病与糖尿病双重负担将成为重大的全球公共卫生问题。因此,需重视结核病与糖尿病共病的治疗管理。本共识重点介绍了结核病与糖尿病共病的危害、发病机制、双向筛查、临床特点、诊断、治疗和管理等内容。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=结核病与糖尿病共病的治疗管理专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=cce191c002038338, title=结核病与糖尿病共病的治疗管理专家共识, enTitle=, guiderFrom=中国防痨杂志, 2021,43(1):12-22., authorId=0, author=, summary=结核病与糖尿病均是临床上的常见病和多发病,两者可合并存在,相互影响。活动性结核病作为感染因素可加重糖尿病病情,而糖尿病患者又是发生结核病的高危人群,结核病与糖尿病双重负担将成为重大的全球公共卫生问题。, cover=https://img.medsci.cn/2021118/1610985529184_2020535.jpg, journalId=0, articlesId=null, associationId=1930, associationName=国家感染性疾病临床医学研究中心, associationIntro=国家感染性疾病临床医学研究中心, copyright=0, guiderPublishedTime=Sun Jan 10 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>结核病与糖尿病均是临床上的常见病和多发病,两者可合并存在,相互影响。活动性结核病作为感染因素可加重糖尿病病情,而糖尿病患者又是发生结核病的高危人群,结核病与糖尿病双重负担将成为重大的全球公共卫生问题。因此,需重视结核病与糖尿病共病的治疗管理。本共识重点介绍了结核病与糖尿病共病的危害、发病机制、双向筛查、临床特点、诊断、治疗和管理等内容。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=216, tagName=糖尿病), TagDto(tagId=380, tagName=结核病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=216, guiderKeyword=糖尿病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=5, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=34988, appHits=264, showAppHits=0, pcHits=831, showPcHits=34724, likes=5, shares=26, comments=20, approvalStatus=1, publishedTime=Tue Jan 19 00:12:33 CST 2021, publishedTimeString=2021-01-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Mon Jan 18 23:59:03 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 20:46:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=结核病与糖尿病共病的治疗管理专家共识.pdf)])
结核病与糖尿病共病的治疗管理专家共识.pdf
下载请点击:
评论区 (15)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1051718, encodeId=f07c1051e1826, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 00:04:20 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005460, encodeId=a1d11005460a0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b0b2382365, createdName=123170b1m40暂无昵称, createdTime=Thu Aug 05 20:52:47 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005459, encodeId=0c9d1005459d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b0b2382365, createdName=123170b1m40暂无昵称, createdTime=Thu Aug 05 20:52:26 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971630, encodeId=d1089e1630f4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/f0e2d89036cb4cfc863e85c133f6a5ce/c81243c1e70a407a90d222cd74ee2b2d.jpg, createdBy=36035144128, createdName=你的宝贝, createdTime=Mon Jun 07 21:41:27 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967395, encodeId=96b796e3958c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50512563389, createdName=妙手先生, createdTime=Fri May 21 09:39:42 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-09-16 湘雅科教

    值得学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1051718, encodeId=f07c1051e1826, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 00:04:20 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005460, encodeId=a1d11005460a0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b0b2382365, createdName=123170b1m40暂无昵称, createdTime=Thu Aug 05 20:52:47 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005459, encodeId=0c9d1005459d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b0b2382365, createdName=123170b1m40暂无昵称, createdTime=Thu Aug 05 20:52:26 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971630, encodeId=d1089e1630f4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/f0e2d89036cb4cfc863e85c133f6a5ce/c81243c1e70a407a90d222cd74ee2b2d.jpg, createdBy=36035144128, createdName=你的宝贝, createdTime=Mon Jun 07 21:41:27 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967395, encodeId=96b796e3958c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50512563389, createdName=妙手先生, createdTime=Fri May 21 09:39:42 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-08-05 123170b1m40暂无昵称

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1051718, encodeId=f07c1051e1826, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 00:04:20 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005460, encodeId=a1d11005460a0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b0b2382365, createdName=123170b1m40暂无昵称, createdTime=Thu Aug 05 20:52:47 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005459, encodeId=0c9d1005459d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b0b2382365, createdName=123170b1m40暂无昵称, createdTime=Thu Aug 05 20:52:26 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971630, encodeId=d1089e1630f4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/f0e2d89036cb4cfc863e85c133f6a5ce/c81243c1e70a407a90d222cd74ee2b2d.jpg, createdBy=36035144128, createdName=你的宝贝, createdTime=Mon Jun 07 21:41:27 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967395, encodeId=96b796e3958c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50512563389, createdName=妙手先生, createdTime=Fri May 21 09:39:42 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-08-05 123170b1m40暂无昵称

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1051718, encodeId=f07c1051e1826, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 00:04:20 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005460, encodeId=a1d11005460a0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b0b2382365, createdName=123170b1m40暂无昵称, createdTime=Thu Aug 05 20:52:47 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005459, encodeId=0c9d1005459d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b0b2382365, createdName=123170b1m40暂无昵称, createdTime=Thu Aug 05 20:52:26 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971630, encodeId=d1089e1630f4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/f0e2d89036cb4cfc863e85c133f6a5ce/c81243c1e70a407a90d222cd74ee2b2d.jpg, createdBy=36035144128, createdName=你的宝贝, createdTime=Mon Jun 07 21:41:27 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967395, encodeId=96b796e3958c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50512563389, createdName=妙手先生, createdTime=Fri May 21 09:39:42 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-06-07 你的宝贝

    学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1051718, encodeId=f07c1051e1826, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 00:04:20 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005460, encodeId=a1d11005460a0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b0b2382365, createdName=123170b1m40暂无昵称, createdTime=Thu Aug 05 20:52:47 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005459, encodeId=0c9d1005459d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b0b2382365, createdName=123170b1m40暂无昵称, createdTime=Thu Aug 05 20:52:26 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971630, encodeId=d1089e1630f4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/f0e2d89036cb4cfc863e85c133f6a5ce/c81243c1e70a407a90d222cd74ee2b2d.jpg, createdBy=36035144128, createdName=你的宝贝, createdTime=Mon Jun 07 21:41:27 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967395, encodeId=96b796e3958c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50512563389, createdName=妙手先生, createdTime=Fri May 21 09:39:42 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-05-21 妙手先生

    学习

    0

拓展阅读

2009 中国糖尿病护理及教育指南

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2009-10-30

2010CARI 2型糖尿病患者的肾功能评估

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010CARI 2型糖尿病患者中慢性肾脏病的预防和管理

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010 AOA(POA)糖尿病患者眼部健康

美国视觉协会(AOA,American Optometric Association) · 2010-01-01

中国糖尿病医学营养治疗指南 (2010年)

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2010-01-01

运动与2型糖尿病联合声明

美国糖尿病学会(ADA,American Diabetes Association) · 2010-01-01